Quantcast

Latest National Institute of Allergy and Infectious Diseases Stories

2012-05-29 09:02:10

Potential role in HIV treatment and prevention under study Scientists have identified a new HIV-suppressing protein in the blood of people infected with the virus. In laboratory studies, the protein, called CXCL4 or PF-4, binds to HIV such that it cannot attach to or enter a human cell. The research was led by Paolo Lusso, M.D., Ph.D., chief of the Section of Viral Pathogenesis in the Laboratory of Immunoregulation at the National Institute of Allergy and Infectious Diseases (NIAID), part...

FDA Approval Gives Us A Chance To Fight Bioterrorism, Plague
2012-04-30 12:33:18

The FDA has announced its approval of the antibacterial agent levofloxacin, or “Levaquin,” to treat and prevent the plague. Manufactured by Johnson & Johnson, Levaquin was approved under the FDA´s Animal Efficacy rule which allows results from animal testing to be studied if such tests on humans aren´t ethical or feasible. Why prevent the plague, and why now? Also known as Yersinia pestis, the plague is considered to be a bioterrorism threat. As such, the US...

2012-04-23 09:29:41

National Institutes of Health (NIH) scientists and their colleagues in China have described a rapidly emerging Staphylococcus aureus gene, called sasX, which plays a pivotal role in establishing methicillin-resistant S. aureus (MRSA) epidemics in most of Asia. Senior author Michael Otto, Ph.D., of NIH's National Institute of Allergy and Infectious Diseases, says these findings illustrate at the molecular level how MRSA epidemics may emerge and spread. Moreover, their study identifies a...

Researchers Follow Up On Potential For HIV Vaccine
2012-04-05 10:16:06

Researchers have discovered crucial hints into how immune system responses play a key role in protecting people from HIV infection. Results from the first ever RV144 HIV vaccine trial were published this week in the New England Journal of Medicine. Scientists found that among Thai adults who received an experimental vaccine during a clinical trial, those who produced relatively high levels of a specific antibody after vaccination were less likely to become infected with the virus than...

2012-04-05 09:46:20

Analysis by NIH-supported scientists may help identify requirements for HIV vaccine Insights into how the first vaccine ever reported to modestly prevent HIV infection in people might have worked were published online today in the New England Journal of Medicine. Scientists have found that among adults who received the experimental HIV vaccine during the landmark RV144 clinical trial (http://www.niaid.nih.gov/news/newsreleases/2009/pages/thaivaxstudy.aspx), those who produced relatively...

2012-03-20 11:25:48

In the past decade, scientists have made significant progress building the critical knowledge and infrastructure needed to identify and develop novel tuberculosis (TB) vaccine candidates and move the most promising ones into human clinical trials. The results of those trials, coupled with advances from other TB studies, have paved the way for the next 10 years of research on TB vaccines, a critical component of TB control efforts, note scientists at the National Institute of Allergy and...


Word of the Day
cruet
  • A vial or small glass bottle, especially one for holding vinegar, oil, etc.; a caster for liquids.
This word is Middle English in origin, and ultimately comes from the Old French, diminutive of 'crue,' flask.
Related